Kunling Wan improves oocyte quality by regulating the PKC/Keap1/Nrf2 pathway to inhibit oxidative damage caused by repeated controlled ovarian hyperstimulation

Fengli Guan; Shuancheng Zhang; Lijie Fan; Ying Sun; Yucong Ma; Can Cao; Yu Zhang; Ming He; Huilan Du

doi:10.1016/j.jep.2022.115777

Kunling Wan improves oocyte quality by regulating the PKC/Keap1/Nrf2 pathway to inhibit oxidative damage caused by repeated controlled ovarian hyperstimulation

Fengli Guan, Shuancheng Zhang, Lijie Fan, Ying Sun, Yucong Ma, Can Cao, Yu Zhang, Ming He, Huilan Du

In: Journal of Ethnopharmacology · 2022 · vol. 301 , pp. 115777 · doi:10.1016/j.jep.2022.115777 · PMID:36191663 · W4298395529

article OA: closed CC0 ⤵ 1 in-corpus citation

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-12 ⓘ

Kunling Wan treatment improved oocyte quality by inhibiting oxidative damage through regulation of the PKC/Keap1/Nrf2 pathway in repeatedly hyperstimulated mice.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

N-Acetylcysteine improves oocyte quality through modulating the Nrf2 signaling pathway to ameliorate oxidative stress caused by repeated controlled ovarian hyperstimulation 2022

Cited by (1)

Exploring the therapeutic potential of tonic Chinese herbal medicine for gynecological disorders: An updated review 2024

References (63)

N-Acetylcysteine improves oocyte quality through modulating the Nrf2 signaling pathway to ameliorate oxidative stress caused by repeated controlled ovarian hyperstimulation via openalex
doi:10.1016/0140-6736(91)93060-m via openalex
doi:10.1016/j.freeradbiomed.2010.05.025 via openalex
doi:10.1186/1477-7827-12-111 via openalex
doi:10.1111/1440-1681.12193 via openalex
doi:10.1071/rd14182 via openalex
doi:10.1006/bbrc.1997.6943 via openalex
doi:10.1071/rd15184 via openalex
doi:10.1272/jnms.70.408 via openalex
doi:10.1073/pnas.1305687110 via openalex
doi:10.1093/molehr/4.3.269 via openalex
doi:10.1242/dev.00296 via openalex
W108185548 via openalex
doi:10.1016/0009-8981(95)98130-9 via openalex
doi:10.1093/molehr/4.1.41 via openalex
doi:10.1186/1477-7827-10-49 via openalex
doi:10.1111/j.1439-0531.2005.00592.x via openalex
doi:10.1210/me.2009-0033 via openalex
doi:10.1016/j.theriogenology.2008.03.012 via openalex
doi:10.1093/humrep/des019 via openalex
doi:10.1159/000485089 via openalex
doi:10.18632/aging.101449 via openalex
doi:10.1038/srep19436 via openalex
W2256393506 via openalex
doi:10.1016/j.fertnstert.2018.10.036 via openalex
doi:10.18632/aging.101609 via openalex
doi:10.1002/cphy.c150051 via openalex
doi:10.1262/jrd.2017-042 via openalex
doi:10.1186/s12958-017-0292-z via openalex
doi:10.1007/978-3-319-60855-6_16 via openalex
doi:10.1530/jme-19-0093 via openalex
doi:10.1007/s43032-020-00359-4 via openalex
doi:10.1002/jcp.30468 via openalex
W6604357965 via openalex
W6714206614 via openalex
W6791226807 via openalex
doi:10.3390/antiox9060472 via openalex
doi:10.1016/j.theriogenology.2019.08.019 via openalex
doi:10.1002/jcp.29219 via openalex
doi:10.1002/jcp.28018 via openalex
doi:10.5935/1518-0557.20220001 via openalex
doi:10.1111/micc.12581 via openalex
doi:10.1016/j.freeradbiomed.2019.07.017 via openalex
doi:10.1007/s00441-019-02990-3 via openalex
doi:10.1016/j.theriogenology.2020.01.048 via openalex
doi:10.3389/fphys.2021.525145 via openalex
doi:10.1093/humrep/deaa300 via openalex
doi:10.1017/s096719941900008x via openalex
doi:10.3389/fphar.2021.565748 via openalex
doi:10.1177/1073858415585472 via openalex
doi:10.3390/antiox9111080 via openalex
doi:10.1016/j.rbmo.2010.10.011 via openalex
doi:10.3168/jds.2017-13389 via openalex
doi:10.1001/jama.2015.17296 via openalex
doi:10.1096/fj.201802473r via openalex
doi:10.1007/s12522-015-0209-5 via openalex
doi:10.1073/pnas.68.5.1024 via openalex
doi:10.1126/scisignal.3112re3 via openalex
doi:10.1111/j.1600-079x.2007.00524.x via openalex
doi:10.3390/antiox9100933 via openalex
doi:10.1016/j.chemosphere.2019.125086 via openalex
doi:10.1093/humrep/16.3.513 via openalex
doi:10.1016/j.mrfmmm.2009.09.007 via openalex

Cited by (1)

Exploring the therapeutic potential of tonic Chinese herbal medicine for gynecological disorders: An updated review 2024

Source provenance

openalex: last seen: 2026-05-11T06:02:20.344922+00:00

License: CC0 · commercial use OK

[1] N-Acetylcysteine improves oocyte quality through modulating the Nrf2 signaling pathway to ameliorate oxidative stress caused by repeated controlled ovarian hyperstimulation 2022